We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
PNC Financial Services
PNC
$92.4B
| $543K | 0.01% |
6,100
+1,726
| +39% | +$147K |
|
677
Expeditors International
EXPD
$24.6B
| $541K | 0.01% |
+12,243
| New | +$527K |
|
678
NVR
NVR
$16.5B
| $534K | 0.01% |
464
+192
| +71% | +$214K |
|
679
International Paper
IP
$18B
| $531K | 0.01% |
11,270
-3,609
| -24% | -$158K |
|
|
LLTC
680
DELISTED
Linear Technology Corp
LLTC
| $529K | 0.01% |
+11,247
| New | +$521K |
|
|
CY
681
DELISTED
Cypress Semiconductor
CY
| $528K | 0.01% |
48,412
+34,225
| +241% | +$347K |
|
682
Genworth Financial
GNW
$3.81B
| $527K | 0.01% |
30,271
-413,374
| -93% | -$7.23M |
|
683
Southern Company
SO
$99.2B
| $527K | 0.01% |
11,623
-12,219
| -51% | -$540K |
|
684
Alexandria Real Estate Equities
ARE
$9.21B
| $526K | 0.01% |
+6,776
| New | +$508K |
|
|
WFT
685
DELISTED
Weatherford International plc
WFT
| $522K | 0.01% |
22,700
-21,104
| -48% | -$434K |
|
686
Manitowoc
MTW
$753M
| $521K | 0.01% |
17,520
-379,706
| -96% | -$10.1M |
|
687
AbbVie
ABBV
$464B
| $519K | 0.01% |
+9,200
| New | +$483K |
|
688
Tyson Foods
TSN
$18.3B
| $518K | 0.01% |
13,801
+4,671
| +51% | +$187K |
|
|
AVP
689
DELISTED
Avon Products, Inc.
AVP
| $518K | 0.01% |
35,461
+17,689
| +100% | +$255K |
|
690
First Horizon
FHN
$11.3B
| $517K | 0.01% |
43,553
+23,678
| +119% | +$277K |
|
|
SCG
691
DELISTED
Scana
SCG
| $516K | 0.01% |
9,583
+4,896
| +104% | +$254K |
|
692
Cincinnati Financial
CINF
$26.2B
| $514K | 0.01% |
+10,698
| New | +$520K |
|
693
iShares Biotechnology ETF
IBB
$10.3B
| $514K | 0.01% |
+6,000
| New | +$473K |
|
694
Deluxe
DLX
$1.08B
| $512K | 0.01% |
8,744
-27,616
| -76% | -$1.51M |
|
695
Aecom
ACM
$8.08B
| $508K | 0.01% |
15,781
+6,651
| +73% | +$215K |
|
|
CVSA
696
Covista Inc
CVSA
$4.33B
| $507K | 0.01% |
+11,964
| New | +$509K |
|
697
Qualcomm
QCOM
$197B
| $507K | 0.01% |
+6,400
| New | +$509K |
|
|
SAFM
698
DELISTED
Sanderson Farms Inc
SAFM
| $506K | 0.01% |
+5,201
| New | +$450K |
|
699
AXIS Capital
AXS
$7.27B
| $505K | 0.01% |
11,394
+4,844
| +74% | +$221K |
|
|
TECD
700
DELISTED
Tech Data Corp
TECD
| $505K | 0.01% |
+8,078
| New | +$501K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.